Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 1 | 3674884 | intron variant | G/C | snv | 0.38 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 1 | 3703616 | intron variant | A/T | snv | 0.33 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 1 | 3705742 | intron variant | T/A;C;G | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.120 | 1 | 3730017 | missense variant | C/G;T | snv | 8.2E-06; 8.2E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2001 | |||||||
|
0.925 | 0.120 | 1 | 3731497 | missense variant | G/A | snv | 1.6E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2001 | 2001 | |||||||
|
0.925 | 0.120 | 1 | 3731497 | missense variant | G/A | snv | 1.6E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2001 | 2001 | |||||||
|
0.925 | 0.120 | 1 | 3731497 | missense variant | G/A | snv | 1.6E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2001 | 2001 | |||||||
|
0.851 | 0.120 | 1 | 3707593 | missense variant | C/A | snv | 2.1E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.851 | 0.120 | 1 | 3707593 | missense variant | C/A | snv | 2.1E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.851 | 0.120 | 1 | 3707593 | missense variant | C/A | snv | 2.1E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.851 | 0.120 | 1 | 3707593 | missense variant | C/A | snv | 2.1E-05 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
1 | 3732853 | missense variant | G/A | snv | 1.7E-05 | 2.8E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.851 | 0.120 | 1 | 3682346 | 5 prime UTR variant | C/T | snv | 0.20 | 0.18 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.851 | 0.120 | 1 | 3682346 | 5 prime UTR variant | C/T | snv | 0.20 | 0.18 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.851 | 0.120 | 1 | 3682346 | 5 prime UTR variant | C/T | snv | 0.20 | 0.18 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.851 | 0.120 | 1 | 3682346 | 5 prime UTR variant | C/T | snv | 0.20 | 0.18 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.851 | 0.120 | 1 | 3682346 | 5 prime UTR variant | C/T | snv | 0.20 | 0.18 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.851 | 0.120 | 1 | 3682336 | 5 prime UTR variant | G/A;T | snv | 0.20; 3.3E-04 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.120 | 1 | 3682336 | 5 prime UTR variant | G/A;T | snv | 0.20; 3.3E-04 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.120 | 1 | 3682336 | 5 prime UTR variant | G/A;T | snv | 0.20; 3.3E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.120 | 1 | 3682336 | 5 prime UTR variant | G/A;T | snv | 0.20; 3.3E-04 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.120 | 1 | 3682336 | 5 prime UTR variant | G/A;T | snv | 0.20; 3.3E-04 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 1 | 3690286 | intron variant | G/A;T | snv |
|
Nervous System Diseases; Mental Disorders | 0.010 | < 0.001 | 1 | 2014 | 2014 | ||||||||
|
0.882 | 0.120 | 1 | 3716166 | intron variant | G/A | snv | 0.32 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.120 | 1 | 3716166 | intron variant | G/A | snv | 0.32 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 |